Oncocyte Corporation Revenue and Competitors
Estimated Revenue & Valuation
- Oncocyte Corporation's estimated annual revenue is currently $10.2M per year.
- Oncocyte Corporation's estimated revenue per employee is $182,679
Employee Data
- Oncocyte Corporation has 56 Employees.
- Oncocyte Corporation grew their employee count by 4% last year.
Oncocyte Corporation's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | SVP Business Operations | Reveal Email/Phone |
4 | SVP Business Development | Reveal Email/Phone |
5 | Controller & Principal Accounting Officer | Reveal Email/Phone |
6 | VP, General Counsel | Reveal Email/Phone |
7 | VP, General Counsel | Reveal Email/Phone |
8 | VP, Medical Affairs | Reveal Email/Phone |
9 | Senior Director, Pharma R&D | Reveal Email/Phone |
10 | Associate Director Quality | Reveal Email/Phone |
Oncocyte Corporation Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 5 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 4 | -50% | N/A | N/A |
#6 | $0.7M | 8 | 0% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 17 | 31% | N/A | N/A |
What Is Oncocyte Corporation?
Oncocyte is a molecular diagnostics company whose mission is to provide actionable answers to physicians and patients at critical decision points along the lung cancer care continuum, to optimize diagnosis and treatment, improve patient outcomes, and reduce overall cost of care. For more information, visit www.oncocyte.com.
keywords:N/AN/A
Total Funding
56
Number of Employees
$10.2M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Oncocyte Corporation News
IRVINE, Calif., April 13, 2022 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), (Oncocyte or the Company),...
ONCOCYTE CORPORATION. OCX. Delayed Quote. Delayed - 04/14 04:00:00...
IRVINE, Calif., March 28, 2022 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company with the mission to...
OncoCyte actually draws its diagnostic capability from the kind of stem cell research going on at BioTime – because the company itself pivoted away from embryonic stem cell-based cancer therapeutics and into the diagnostics space. Several genes associated with embryonic stem cell growth are rea ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $12.8M | 56 | 0% | N/A |
#2 | $17.3M | 56 | 2% | N/A |
#3 | $7.3M | 56 | 4% | N/A |
#4 | $3.5M | 56 | 40% | N/A |
#5 | $5.2M | 56 | 30% | N/A |